Stereotactic Ablative Radiation Therapy for Abiraterone-Resistant, Oligoprogressive Metastatic Prostate Cancer

Abroad (travel likely)Recruiting

Conditions

Oligoprogressive · Castration-Resistant Prostate Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Odette Cancer Centre, Toronto, Ontario, Canada
Contact: Study coordinator (Urban Emmenegger, MD) · urban.emmenegger@sunnybrook.ca · +1-416-480-4928

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)

Prostate Cancer · Oligoprogressive · Urothelial Carcinoma

Abroad (travel likely)Recruiting

Sacramento, United States

Stereotactic Magnetic Resonance Guided Radiation Therapy

Pancreas Cancer · Lung Cancer · Renal Cancer

Abroad (travel likely)Recruiting

Boston, United States · Boston, United States

Metastasis-directed Therapy in Oligoprogressive Castration-refractory Prostate Cancer

Castration-resistant Prostate Cancer · Oligoprogressive

Abroad (travel likely)RecruitingPHASE3

Leuven, Belgium

Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma

Renal Cell Carcinoma · Metastatic Renal Cell Carcinoma · Oligoprogressive

Abroad (travel likely)RecruitingPHASE2

New Haven, United States